CD14 and Hepatic fibrosis: In this respect, it is important to point out that the most prominent enrichment of these non-classical CD14+CD16+ monocytes in peripheral blood and in the liver was observed in patients with liver cirrhosis, in contrast to the similar levels observed between healthy volunteers and CLD patients at early stages of liver fibrosis.